DISLOG GROUP CLOSES SOMAPHARMA AND STERIPHARMA OPERATIONS

Dislog Group takes part in the Morocco Capital Markets Days organized by the Casablanca Stock Exchange in partnership with the AMMC, and contacts international investors with a view to its IPO planned for late 2024.

Dislog Group is preparing its IPO, scheduled for the last quarter of 2024. In line with the vision of its reference shareholder, the Group's top management team, represented by Mehdi Bouamrani, CEO Operations, and Zakarya Jerrari, CEO Finance, met with investors and institutional investors at the Morocco Capital Markets Days (MCDM), organized in London on April 26 and 27 by the Casablanca Stock Exchange and supported by the Moroccan Capital Market Authority (AMMC).

The aim was to meet with investment banks and international investment funds interested in investing in Morocco. During the MCDM plenary conference and one-to-one sessions, management initiated talks with several investors. "We seized this pre-IPO opportunity to make ourselves known to the international financial market, and contact has been well established. This mobilization is part of our preparations for our IPO, and I can say that we're on the right track", says Zakaria Jerrari, Dislog Group's Managing Director of Finance.

An IPO is not an end in itself...

The IPO will enable the Group to accelerate its development, particularly internationally, and will represent a high-potential investment opportunity for investors.

In fact, this operation has been the subject of meticulous preparation, as part of a long-term development strategy aimed at turning Dislog into a major industrial group, with expertise across the entire value chain in fast-growing markets. "Dislog Group has solid financial fundamentals. Our corporate governance is no exception. We have a high level of corporate governance. In addition, we have a clear strategic vision, capable of creating maximum added value for both existing and future shareholders," emphasizes Dislog's Chief Operating Officer.

Under the impetus of its reference shareholder, Dislog Group works on a daily basis to bring consumers closer to essential brands in the food, household and personal care sectors, as well as in health, OTC and parapharmacy products.

At the same time, the Group has embarked on a policy of expansion, starting in 2020, with the aim of becoming one of the major industrial players in the FMCG sector, including pharmaceuticals. This is a niche that the Group is constantly strengthening through a series of acquisitions. After joining Kosmopharm's round table in March 2022, Dislog Group recently announced the acquisition of 100 % of the shares in pharmaceutical promotion company Somapharma and 89 % of the shares in pharmaceutical laboratory Steripharma. The closing of this transaction is scheduled for the end of June 2023.

In addition to local development, the group spread its wings in France with the acquisition of Cultures de France, a company specializing in the bio-industry of soups, sauces and juices, based in Cavaillon in the South of France, shortly after acquiring Chocolatier Carré Suisse in France.

Other initiatives aimed at potential investors are in the pipeline and will be unveiled in the coming days.

The Dislog Group currently has several business units, which it intends to strengthen through further acquisitions, necessitating a capital increase, hence the IPO.
What's more, the reference shareholder wants to be part of the country's drive to make the Casablanca stock exchange a leading financial center on the African continent.

Share

Empowering Your Laboratories with Excellence

Since 1992, Megaflex SARL has established itself as a key force in the medical sector in Morocco. We are more than just a supplier: we are the strategic partner that supports laboratories in their pursuit of innovation, efficiency, and performance.

Market leader: Over 30 years of expertise and a reputation built on quality, reliability, and innovation.
Global partnerships: We collaborate with the best international brands to provide cutting-edge technology.
National presence: Extensive coverage and dedicated customer service to support you every step of the way.

At Megaflex, we believe every laboratory deserves solutions that combine advanced technology with ease of use. Our mission is clear: to provide you with the tools to excel in your field while optimizing your resources.

For further information:
www.megaflex.ma

25 Years Serving the Pharmaceutical Industry

With 25 years of presence in the Moroccan market, FARMALAC has grown into a dynamic company specializing in the research, development, and distribution of raw materials and packaging components . We collaborate with renowned partners in the pharmaceutical industry and take pride in the journey we’ve built.

Today, FARMALAC is a well-established company with recognized expertise and a loyal customer base. Thanks to our deep understanding of the Moroccan market, we are confident in our ability to meet our clients’ specific needs by sourcing new products and identifying new suppliers.

FARMALAC follows a strict partner selection policy, choosing only companies that offer high-quality products certified under ISO 9001 and ISO 15378 standards. This ensures that our clients receive materials that comply with international Good Manufacturing Practices (GMP).

For further information:
www.farmalac.ma

MEDICAL EXELLENCE

We take pride in being your trusted supplier of medical devices, particularly cardiology equipment. Since 2009, we’ve been present in the Moroccan and African markets, committed to delivering the latest technologies to support healthcare professionals in their vital work.

At AFROBIOMEDIC, we are passionate about our mission to provide innovative medical solutions that improve patients’ quality of life. With in-depth expertise in cardiology, we offer cutting-edge equipment designed to meet the highest professional standards.

We work with the industry’s leading manufacturers to ensure the quality and reliability of our products. Our skilled pre-sales and after-sales service teams are also here to help you deliver personalized care to your patients.

We sincerely thank all our clients and partners for their continued trust and support. We look forward to continuing our collaboration to provide outstanding medical solutions.

For further information:
www.afrobiomedic.com

Dislog Group operates in the healthcare sector through a strong presence in the pharmaceutical industry. A pillar of Morocco’s pharmaceutical landscape, KPH Pharmaceutical Laboratories are recognized leaders in the manufacturing of dermo-cosmetic products, with iconic brands such as Kaline and Argapur, alongside a wide range of pharmaceutical products and dietary supplements.

KPH Pharmaceutical Laboratories’ production spans multiple therapeutic areas, including dermatology, gynecology, pediatrics, pulmonology, surgery, internal medicine, and general medicine. The laboratories offer innovative solutions to meet the needs of both patients and healthcare professionals.

Modern pharmaceutical laboratories

Our laboratories are equipped with cutting-edge technology and adhere to the highest international standards. All medicines are manufactured following rigorous global pharmaceutical guidelines. KPH Pharmaceutical Laboratories operate a 2,800 m² facility that complies with European standards, Good Distribution Practices (GDP), and Health, Safety & Environment (HSE) requirements.

products & services

FULL SERVICE PROVIDER

KPH Laboratories specialize in the design and production of dietary supplements and cosmetics. Our expertise ensures high-quality manufacturing that meets the expectations of our clients and partners.
visit the site

GAME PRIVATE LABEL

We offer a wide selection of white-label dietary supplements, developed in line with market trends and fully compliant with regulations.
visit the site

LOGISTICS

Our logistics team ensures the procurement and delivery of medicines to pharmacies. We follow an accredited logistics model with strict control across the entire value chain.
visit the site

DISTRIBUTION

Our modern distribution center includes specialized storage zones, five cold rooms, and a secured containment room. We ship over 70 million units annually to wholesalers, hospitals, clinics, and pharmacies across Morocco and internationally.
visit the site

DRUGS

Our medical range addresses essential healthcare needs. It includes POLYFER, an iron syrup dosed at 50 mg/5 ml in a 150 ml bottle, and AMYKON, an antifungal cream in a 15g tube — both developed according to the highest pharmaceutical standards.
visit the site

DIETARY SUPPLEMENTS

To support optimal daily health, we offer a comprehensive range that includes COMBIVIT in sugar-free effervescent tablets, PRONATAL in 375 mg capsules, and STRATH, available as 50g tablets or a 125 ml fortifying syrup.
visit the site

PARAMEDICAL PRODUCTS

Our parapharmaceutical line offers targeted solutions for various needs: SIACEN for skin repair and healing, SOLUELASTINE for stretch mark treatment, and SCARGEL, specially formulated for scar care.
visit the site

DERMO-COSMETICS

Our dermocosmetic range includes Kaline, designed for sensitive skin, and Argapur, formulated with pure argan oil. Each product is developed to the highest quality standards, combining effectiveness, safety, and user comfort.
visit the site
OUR CERTIFICATIONS

Founded in 1999, Steripharma is one of the leading Moroccan players in the field of generic medicines.
For over 20 years, Steripharma has established itself in Morocco, the Maghreb, and across the African continent as a recognized contract manufacturer, developer, and distributor.

Our product range covers 90% of major therapeutic areas, offering both retail and hospital medications.

Steripharma employs over 200 collaborators across various areas of expertise.

THERAPEUTIC AREAS

Dental

Pharmaceutical solutions dedicated to oral health, designed to meet the standards of professionals in the sector.
visit the site

Cardiology and blood system

Essential drugs for the management of cardiovascular and hematological diseases.
visit the site

Infectiology and parasitology

Rigorous treatment of bacterial, viral and parasitic infections, in line with public health needs.
visit the site

Respiratory system

Effective treatments for acute and chronic respiratory ailments, focused on the patient's well-being.
visit the site

Ophthalmology

Treatments adapted to ocular pathologies, combining tolerance and therapeutic efficacy.
visit the site

Dermatology

Targeted range of dermatological treatments covering the most common skin conditions.
visit the site

Digestive system

Products adapted to the most common gastrointestinal disorders and metabolic imbalances.
visit the site

CNS (Central Nervous System)

Therapeutic solutions for neurological and musculoskeletal disorders, focused on improving mobility and comfort.
visit the site
OUR CERTIFICATIONS